Jushi Holdings (JUSHF) Deferred Taxes (2021 - 2022)
Jushi Holdings (JUSHF) posted quarterly Deferred Taxes of -$18.9 million for Q4 2022, down 320.2% year-over-year from $8.6 million in Q4 2021, and down 71.71% quarter-over-quarter from -$11.0 million in Q3 2022.
Jushi Holdings (JUSHF) Deferred Taxes (2021 - 2022) Analysis & Trends
Jushi Holdings (JUSHF) has reported Deferred Taxes for 2 consecutive years, with -$18.9 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Deferred Taxes fell 320.2% year-over-year to -$18.9 million; the TTM figure through Dec 2022 stood at -$40.4 million (changed N/A YoY), while the FY2025 annual figure was -$6.1 million, up 21.86% from the prior year.
- Deferred Taxes slipped to -$18.9 million in Q4 2022 per JUSHF's latest filing, from -$11.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at -$4.5 million in Q4 2021 and bottomed at -$18.9 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -18.93 Mn |
| Sep 30, 2022 | -11.02 Mn |
| Dec 31, 2021 | -4.50 Mn |
| Sep 30, 2021 | -5.92 Mn |